TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
Clinical trial NCT05220020 · UNKNOWN
Trial details
- NCT number
- NCT05220020
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-18
- Primary completion
- 2024-02-28
- Enrollment
- 299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.